Appointment of new Medical Director

RNS Number : 8885P

Feedback PLC

01 June 2018

 

1 June 2018

Feedback plc

("Feedback" or the "Company")

Appointment of new Medical Director

Cambridge, UK - 1 June 2018: Feedback plc ("Feedback" or the "Company") (AIM: FDBK), the specialist medical imaging technology company, announces the appointment of Professor Rory Shaw as Medical Director of Feedback's subsidiary company, Feedback Medical Limited, effective immediately. 

Professor Shaw is a highly experienced NHS executive with a strong track record in strategy development and international relations.  In November 2013, he was appointed as Medical Director of Healthcare UK, part of the Department of International Trade, to lead the NHS International Development Team.  In this role, Professor Shaw was responsible for building relationships between the NHS and foreign governments and healthcare providers in order to leverage opportunities overseas.  Prior to this, Professor Shaw was a medical director in the NHS for over 15 years, latterly at North West London Hospitals Trust, and previously at Royal Berkshire Foundation Trust and Hammersmith Hospitals Trust.  He has also held national roles as non-executive of the NHS Litigation Authority and previously as the first Chairman of the National Patient Safety Agency.  Professor Shaw is a consultant respiratory physician and is a named author on over 140 scientific publications.

David Crabb, Chief Executive Officer of Feedback plc, said: "With a unique combination of clinical and international engagement experience, Professor Shaw brings a highly complementary skill-set to the team.  His clinical input, together with Dr Balaji Ganeshan's market expertise, will underpin our product development strategy following the first CE marked release of the TexRAD^® technology.  Furthermore, Professor Shaw's international reach will be invaluable as we continue to pursue opportunities to increase TexRAD and Cadran platform technology sales globally."

Professor Rory Shaw, Medical Director of Feedback Medical Limited, commented: "The TexRAD technology provides a way of obtaining a new level of information about cancers by using Artificial Intelligence to undertake an in-depth analysis of CT scans and other images.  The next exciting phase is to understand how this new information can be used in the clinical care of patients with diseases such as lung cancer, to enable better disease staging and thus to enable more effective cancer treatment."

Professor Shaw will also be appointed as a Director of Feedback Medical Limited.

- Ends -

Notes to editors

About Feedback plc

Feedback plc is a specialist medical imaging technology company. It develops software and systems that provide innovative techniques and improved workflows for practitioners involved in medical research and treating patients. TexRAD^®, the Company's patented quantitative image texture analysis technology, has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer and is currently installed in over 40 of the world's leading research institutions across Europe, North America, Asia and Australasia. The Cadran platform provides a suite of medical imaging tools for decision support. The Cadran range includes the picture archiving communication system (PACS) to provide decision support for scan analysis, diagnostic workstations which provide secure remote access to view scans on demand, and products to securely share and transport patient data. Visit www.fbk.com.

For further information, please contact:

Feedback plc David Crabb, Chief Executive Officer Lara Mott, Investor Relations

Tel: [phone] [e-mail]

 

END

 

 

NRAZMGFKFMRGRZM